These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens. Carrel S, Schmidt-Kessen A, Giuffrè L. Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869 [Abstract] [Full Text] [Related]
3. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines. Kelley VE, Fiers W, Strom TB. J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799 [Abstract] [Full Text] [Related]
4. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. Shaw AR, Chan JK, Reid S, Seehafer J. J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246 [Abstract] [Full Text] [Related]
5. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells. Nisticò P, Tecce R, Giacomini P, Cavallari A, D'Agnano I, Fisher PB, Natali PG. Cancer Res; 1990 Dec 01; 50(23):7422-9. PubMed ID: 1701342 [Abstract] [Full Text] [Related]
6. Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines. Virelizier JL, Perez N, Arenzana-Seisdedos F, Devos R. Eur J Immunol; 1984 Jan 01; 14(1):106-8. PubMed ID: 6420168 [Abstract] [Full Text] [Related]
7. Interferons as modulators of human monocyte-macrophage differentiation. I. Interferon-gamma increases HLA-DR expression and inhibits phagocytosis of zymosan. Becker S. J Immunol; 1984 Mar 01; 132(3):1249-54. PubMed ID: 6420462 [Abstract] [Full Text] [Related]
8. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma. Gonwa TA, Frost JP, Karr RW. J Immunol; 1986 Jul 15; 137(2):519-24. PubMed ID: 3088102 [Abstract] [Full Text] [Related]
9. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. Tsujisaki M, Igarashi M, Sakaguchi K, Eisinger M, Herlyn M, Ferrone S. J Immunol; 1987 Feb 15; 138(4):1310-6. PubMed ID: 3100635 [Abstract] [Full Text] [Related]
10. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons. Giacomini P, Gambari R, Barbieri R, Nisticò P, Tecce R, Pestka S, Gustafsson K, Natali PG, Fisher PB. Anticancer Res; 1986 Feb 15; 6(5):877-84. PubMed ID: 2432832 [Abstract] [Full Text] [Related]
11. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4. Guo TL, Mudzinski SP, Lawrence DA. Cell Immunol; 1996 Jul 10; 171(1):1-9. PubMed ID: 8660831 [Abstract] [Full Text] [Related]
12. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells. Berrih S, Arenzana-Seisdedos F, Cohen S, Devos R, Charron D, Virelizier JL. J Immunol; 1985 Aug 10; 135(2):1165-71. PubMed ID: 3925000 [Abstract] [Full Text] [Related]
13. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential. Maio M, Gulwani B, Langer JA, Kerbel RS, Duigou GJ, Fisher PB, Ferrone S. Cancer Res; 1989 Jun 01; 49(11):2980-7. PubMed ID: 2497970 [Abstract] [Full Text] [Related]
18. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection. Andrews PW, Trinchieri G, Perussia B, Baglioni C. Cancer Res; 1987 Feb 01; 47(3):740-6. PubMed ID: 3026615 [Abstract] [Full Text] [Related]
20. Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability. Takiguchi M, Ting JP, Buessow SC, Boyer C, Gillespie Y, Frelinger JA. Eur J Immunol; 1985 Aug 01; 15(8):809-14. PubMed ID: 2411569 [Abstract] [Full Text] [Related] Page: [Next] [New Search]